Q: What will you be speaking about at DisruptHR?
At DisruptHR, I’ll be speaking about the transformative potential of psychedelic-assisted therapy (PAT), with a focus on ketamine-assisted therapy (KAT), as the next big employee benefit. I will cover the history and science behind PAT/KAT, its significant benefits for mental health outcomes and productivity, current legal status and regulations, and real-world case studies of successful employer integrations. This quick pitch aims to showcase how employers can lead in mental health care by adopting innovative, effective treatments, ultimately setting new standards for workplace well-being.
Q: Tell us about yourself.
A: My name is Sherry Rais, and I am the CEO and co-founder of Enthea. Throughout my career, I’ve supported numerous startups, nonprofits, academic institutions, and small businesses in fundraising and enhancing operational efficiency. My work is driven by a strong belief in living and working with purpose. I am dedicated to expanding access to psychedelic-assisted therapy to help alleviate human suffering.
Before founding Enthea, I spent over a decade consulting for the United Nations and World Bank, implementing national-level poverty reduction programs in over 35 countries. I hold a master’s degree in public policy from the London School of Economics and a bachelor’s degree in psychology from McGill University. I also completed a certificate in psychedelic therapies and research from the California Institute of Integral Studies in 2021.
In addition to my role at Enthea, where we focus on providing safe and affordable psychedelic therapy through licensed health plan benefits, I serve as the executive director of the Boston Psychedelic Research Group and as a strategic advisor for the California Institute of Integral Studies.
Q: Why are you passionate about your topic?
A: I am passionate about this topic because I have seen firsthand how psychedelic-assisted therapy can transform lives. Traditional mental health treatments often fall short, leaving many people struggling with unresolved issues. By expanding access to innovative therapies like ketamine-assisted therapy, we can address the root causes of mental health conditions, providing rapid and lasting relief. My mission is to help employers recognize the immense potential of these treatments, not only to improve employee well-being but also to foster a more productive and compassionate workplace. Witnessing the profound healing and positive changes in individuals drives my commitment to advocating for these groundbreaking therapies.
Q: What general business advice do you have for readers out there?
A: My general business advice is to prioritize cultivating a strong, positive workplace culture. A thriving culture promotes employee engagement, productivity, and retention. Encourage open communication, recognize and reward achievements, and foster an environment where employees feel valued and supported. Investing in your team’s growth and well-being will ultimately drive business success!
